DSpace
 

Academic Knowledge Archives of Gunma Institutes >
群馬大学(Gunma University) >
30 医学系研究科 >
3005 北関東医学会 >
330501 The Kitakanto medical journal >
Vol.55 (2005) >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10087/4384

Title: Metformin Use in an Obese Diabetic Patient from Weeks 1 to 21 of Pregnancy.
Authors: Nagai, Takashi
Negishi, Tetuo
Imamura, Makoto
Mori, Masatomo
Keywords: metformin
continuous subcutaneous insulin injection
macrosomia
Issue Date: 1-Feb-2005
Publisher: 北関東医学会
Citation: The Kitakanto medical journal. 55(1), 37-39 (2005)
Abstract: A 43-year-old diabetic woman was admitted in the 15th week of her first pregnancy. When HbAlc levels were 8.2%, we began diet therapy and continuous subcutaneous insulin infusion (CSII) therapy. The HbAlc levels subsequently ranged from 6.2 to 6.7%. She was delivered without complications of a healthy male infant (3120g) in the 38th week. Metformin was then administered. Six months later she was diagnosed as being in the 21st week of pregnancy. We changed from metformin to CSII therapy immediately. The HbAlc levels had ranged from 6.0 to 6.4% before the CSII therapy and from 5.8 to 6.3% after the CSII therapy during the entire second pregnancy. A macrosomia delivery (4070g) occurred in the 37th week. Although glycemic control was better during the 2nd pregnancy than the 1st pregnancy, metformin use until the 21st week may have induced macrosomia.
URI: http://hdl.handle.net/10087/4384
ISSN: 1343-2826
Appears in Collections:Vol.55 (2005)

Files in This Item:

File Description SizeFormat
55_37.pdf348.36 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

DSpace Software Copyright © 2002-2010  Duraspace - Feedback